Seven weeks feeding of magnesium and fluoride modifies plasma lipids of hypercholesterolaemic rats in late growth phase

Magnesium Research

Volumn 11, Issue 4, 1998, Pages 271-282

  Luoma, Heikki ^a   Jauhiainen, Matti ^b   Alakuijala, Pekka ^a   Nevalainen, Timo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Fluoride; Magnesium; Plasma lipids lipoproteins; Rat

Indexed keywords

CHOLESTEROL; FLUORIDE; LIPID; LIPOPROTEIN; MAGNESIUM; TRIACYLGLYCEROL;

ANIMAL; ARTERIOSCLEROSIS; ARTICLE; BLOOD; BODY WEIGHT; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYPERCHOLESTEROLEMIA; MALE; RAT; RAT STRAIN;

ANIMALS; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL; DIETARY SUPPLEMENTS; FLUORIDES; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS; MAGNESIUM; MALE; RATS; RATS, MUTANT STRAINS; TRIGLYCERIDES;

EID: 0032239991     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Varo, P. (1974): Mineral element balance and coronary heart disease. Int. J. Vitam. Nutr. Res. 44, 267-273.
2. Marier, H. R., Neri, L.C. & Anderson, T.W (1979): Water hardness, human health and the importance of magnesium. National Health Council Canada. Publication No 17581, Ottawa, Ontario.
3. Seelig, M.S. (1980): Magnesium deficiency in the pathogenesis of cardiovascular diseases. Part II. In: Magnesium deficiency in the pathogenesis of disease. Early roots of cardiovascular, skeletal and renal abnormalities, pp. 141-264. New York: Plenum Medical Books Co.
4. Karppanen, H. (1981): Epidemiological studies on the relationships between magnesium intake and cardiovascular diseases. Artery 9, 190-199.
5. Durlach, J. (1988): Magnesium in clinical practice. London: John Libbey.
6. Altura, B.M. (1991-1992): Basic biochemistry and physiology of magnesium: A brief review. Magnes. Trace Elem. 10, 167-171.
7. Luoma, H., Aromaa, A., Helminen, S., Murtomaa, H., Kiviluoto. L., Punsar. S. & Knekt, P. (1983): Risk of myocardial infarction in Finnish men in relation to fluoride, calcium and magnesium, concentration in drinking water. Acta Med. Scand. 213, 171-176.
8. Bernstein, D.H , Sadowsky, N. Hegsted, D.M., Guri, C. D. & Stare, F.J. (1966): Prevalence of osteoporosis in high- and low-fluoride areas in North Dakota. J. Am. Med. Assoc. 198, 499-504.
9. Schmidt, C.W. (1988): Fluorbelastung des Organismus und Aortensklerose - Gibt es Da Zusammenhänge? Zschr. klin. Chem. klin. Biochem. 12, 203-306.
10. Luoma, H., Helminen, S., Ranta, H., Rytömaa, I. & Meurman, J.H. (1973): Relationships between fluoride and magnesium concentrations in drinking water and some components in serum related to cardiovascular diseases in men from four districts in Finland. Scand. J. Clin. Lab. Invest. 32, 217-224.
11. Punsar, S., Erämetsä, O. Karvonen, M.J. Ryhänen, A., Hilska, P. & Vornamo, H. (1975): Coronary heart disease and drinking water. A search in two Finnish male cohorts for epidemiologic evidence of a water factor. J. Chron. Dis. 28, 259-287.
12. Chiemchaisri, Y. & Phillips, P. H. (1965): Certain factors, including fluoride, which affect magnesium calcinosis in the dog and rat. J. Nutr. 86, 23-28.
13. Pyke, R E. (1973): Relationships of calcium, phosphorus, magnesium, and fluoride in hard- and soft tissue calcification. In: Biological mineralization, pp. 463-485 ed. Zipkin. New York: John Wiley.
14. Luoma, H. (1981): Fluoride in human health and diseases. In: Mineral elements '80. pp. 349-364. Helsinki: Nordforsk, The Academy of Finland and others.
15. Luoma, H. (1989): Risk of myocardial infarction in relation to magnesium and calcium concentrations in drinking water, with some aspects on the magnesium vs. fluoride interactions. In: Magnesium in health and disease, eds. Y. Itokawa & J. Durlach, pp. 183-190. London: John Libbey.
16. Townsend, DW. & Singer, L. (1977): Effect of fluoride on the serum lipids in Guinea pigs. J.Nutr. 107, 97-103.
17. Vatassery, G.T., Ophaug, R.H., & Singer, L. (1980): The effect of fluoride intake on the total lipid, cholesterol and vitamin E levels in sera and liver of guinea pigs on high fat diet. Life Sci. 27: 1961-1966.
18. Singh, J.P., Shasi, X. & Thapar S.P. (1985): Effect of fluride on total lipid, cholesterol and triglyceride levels in liver of albino rabbits. Fluoride 18: 146-148.
19. Luoma, H., Alakuijala, P., Korhonen. A., Nevalainen, T., Kuronen, M. & Jauhiainen, M. (1995): Serum lipoprotein levels in genetically hypercholesterolaemic RICO rats: effects of a high sucrose-cholesterol diet without or with altered magnesium and fluoride content. Scand. J. Clin. Lab. Invest. 55, 495-503.
20. Luoma, H., Metsä-Ketelä, T., Jauhiainen, M., Alakuijala, P., Korhonen, A. & Nevalainen, T. (1997): Effects of dietary fluoride and magnesium supplements on cyclic adenosine monophosphate (cAMP), calcium and magnesium levels in aorta of genetically hypercholesterolaemic rats. Scand. J. Clin. Lab. Invest. 57, 421-426.
21. Müller, K.R., Li, J.R., Dinh, D.M. & Subbiah, M.T.R. (1979): The characteristics and metabolism of a genetically hypercholesteremic rat (RICO). Biochim. Biophys. Acta 574, 334-343.
22. Navia, J.M., Lopez, H. & Harris, R.S. (1969): Purified diet for caries studies with rats. J. Nutr. 97, 133-140.
23. Havel, R.J., Eder. H.A. & Bragdon, J.H. (1955): The determination and chemical composition of ultracentrifugaily separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1453
24. Röschlau, P., Bernt, E. & Gruber, W. (1974): Enzymatische Bestimmung des Gesamtcholesterins im Serum. Zschr. klin. Chem. klin. Biochem. 12, 226-230.
25. Wahlefeld, A.W. (1974): Triglycerides: Determination after enzymatic hydrolysis. In: Methods for enzymatic analysis, ed. H.U. Bergmeyer, pp. 18-31. New York: Academic Press.
26. Takayama, M., Itoh, S., Nagasaki, T. & Tanimizu, I. (1977): A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta 79, 93-98.
27. 14C] phosphatidyl choline between liposomes and human plasma high density lipoprotein. Biochim. Biophys. Acta 712, 444-452.
28. Jauhiainen, M., Metso, J., Pahlman. R., Blomqvist, S., van Tol, A. & Ehnholm, C. (1993): Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268, 4032-4036.
29. Luoma, H. & Nuuja, T. (1977): Caries reduction in rats by phosphate, magnesium and fluoride additions to diet with modification of dental calculus and calcium of the kidneys and aorta. Caries Res. 11, 100-108.
30. Rayssiguier, Y. & Gueux, E. (1986): Magnesium and lipids in cardiovascular disease. J. Am. Coll. Nutr 5, 507-519.
31. Nassir, F., Mazur, A., Giannoni, F., Gueux, E., Davidson, N.O. & Rayssiguier, Y. (1995): Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochim.Biophys.Acta 1257, 125-132.
32. Cardona-Sanclemente, L.E., Ferezou, J. & Lutton, C. (1988): Cholesterol metabolism in the genetically hypercholesteremic (RICO) rat. II. A study of plasma lipoproteins and the effect of dietary cholesterol. Biochim. Biophys. Acta 960, 382-389.
33. Jaya, P. & Kurup, P.S. (1987): Magnesium deficiency and metabolism of lipids in rats fed cholesterol-free and cholesterol-containing diet. Ind. J. Biochem. Biophys. 24, 92-95.
34. Luthringer, C., Rayssiguier, Y., Gueux, E. & Berthelot, A. (1988): Effect of moderate magnesium deficiency on serum lipids, blood pressure, and cardiovascular reactivity in normotensive rats. Br. J. Nutr. 59, 243-250.
35. Rayssiguier, Y., Mazur, A., Cardot, P. & Gueux, E. (1989): Effects of magnesium on lipid metabolism and cardiovascular disease. In: Magnesium in health and disease, ed. Y.Itokawa, J.Durlach, pp. 199-207. London: John Libbey.
36. DenBesten, P.K. & Crenshaw, M.A. (1984): The effects of chronic high fluoride levels on forming enamel in the rat. Archs. Oral Biol. 29, 675-679.
37. Rayssiguier, Y., Gueux, E. & Weiser, D. (1981): Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J. Nutr. 111, 1876-1883.
38. Gueux, E. Rayssiguier, Y., Piot, M-C. & Alcindor, L. (1984): Reduction of plasma lecithin-cholesterol acyltransferase activity by acute magnesium deficiency in the rat. J. Nutr. 114, 1479-1483.
39. Kleiner, H. S. & Allman, D. W. (1982): The effects of fluoridated water on rat urine and tissue cAMP levels. Archs. Oral Biol. 27, 107-112.
40. Allmann, D. W., Dunipace, A., Jaouni, S. & Curro, F.A. (1986): Stimulation of cAMP accumulation in rat aorta and diaphragm by fluorine containing compounds. Res. Communic. Chem. Pathol. Pharmacol. 52, 275-284.
41. Numano, F., Maezava, H., Shimamoto, T. & Adachi, K. (1976): Changes in cyclic AMP and cyclic AMP phosphodiesterase on the progression and regression of experimental atherosclerosis. Ann. N.Y. Acad. Sci. 275, 311-320.
42. Smirnov, V.N., Vyono-Yasentskaya, T.A., Antonov, A.S., Lukashev, M.E., Shirinsky, V.P., Tertov, V.V. & Tkachuk, V. (1990): Vascular signal transduction and atherosclerosis. Ann. N.Y. Acad. Sci. 598, 167-181.
43. Cech, S.Y., Broaddus, W.C. & Maguire, M.E. (1980): Adenylate cyclase: The role of magnesium and other divalent cations. Mol. Cell. Biochem. 33, 67-92.